ArticleJournal of clinical laboratory analysis2018

A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing.

Shiyu Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.